Keryx Biopharma (KERX) – Analyst EPS Change
-
FBR Capital Reiterates Market Perform Following Keryx Biopharma's (KERX) Recent Financing
-
Brean Capital Cuts Price Target on Keryx Biopharma (KERX) Following Announced EU Approval of Fexeric
-
-
-
-
-
Back to KERX Stock Lookup